Finding 1055632 (2021-002)

Significant Deficiency
Requirement
G
Questioned Costs
-
Year
2021
Accepted
2024-07-23

AI Summary

  • Core Issue: The organization lacks controls to ensure compliance with the 25% matching requirement for grant funds.
  • Impacted Requirements: All grant funds must be matched with at least 25% cash or in-kind contributions, and this must be tracked on a grant-by-grant basis.
  • Recommended Follow-Up: Management should develop controls to ensure compliance with the matching requirement to avoid future issues.

Finding Text

2021-002: Matching, Level of Effort, Earmarking: Federal Program: Assistance Listing Nos.: 14.267 Continuum of Care Program Condition: The organization was unable to demonstrate controls over the matching requirement. Criteria: The recipient or subrecipient must match all grant funds, except for leasing funds, with no less than 25 percent of cash or in-kind contributions from other sources. For CoC geographic areas in which there is more than one grant agreement, the 25 percent match must be provided on a grant-by-grant basis. Recipients that are a UFA or are the sole recipient for their Continuum may provide match on a Continuum-wide basis (24 CFR section 578.73(a)). Questioned Costs: There are no questioned costs. Effect: It is more likely that the Organizational will not meet the percent matching requirements since there is no formal set of controls over the requirement. Cause: The Organization did not have good controls on ensuring the matching requirement was meet. Recommendation: In order to prevent future occurrences of this deficiency, we recommend that management develop a set of controls to ensure that they are meeting 25% match. Perspective: This is a systemic issue in that controls over the requirement have not been developed to ensure no issues arise. Repeat: This is not a repeat finding. Responsible Official’s View: The Organization agrees with the finding. See attached corrective action plan.

Categories

Matching / Level of Effort / Earmarking

Other Findings in this Audit

  • 479185 2021-001
    Significant Deficiency
  • 479186 2021-001
    Significant Deficiency
  • 479187 2021-001
    Significant Deficiency
  • 479188 2021-001
    Significant Deficiency
  • 479189 2021-002
    Significant Deficiency
  • 479190 2021-002
    Significant Deficiency
  • 479191 2021-002
    Significant Deficiency
  • 479192 2021-002
    Significant Deficiency
  • 479193 2021-003
    Significant Deficiency
  • 479194 2021-003
    Significant Deficiency
  • 479195 2021-003
    Significant Deficiency
  • 479196 2021-003
    Significant Deficiency
  • 479197 2021-004
    Significant Deficiency
  • 479198 2021-004
    Significant Deficiency
  • 479199 2021-004
    Significant Deficiency
  • 479200 2021-004
    Significant Deficiency
  • 479201 2021-005
    Significant Deficiency
  • 479202 2021-005
    Significant Deficiency
  • 479203 2021-005
    Significant Deficiency
  • 479204 2021-005
    Significant Deficiency
  • 479205 2021-005
    Significant Deficiency
  • 479206 2021-005
    Significant Deficiency
  • 479207 2021-005
    Significant Deficiency
  • 1055627 2021-001
    Significant Deficiency
  • 1055628 2021-001
    Significant Deficiency
  • 1055629 2021-001
    Significant Deficiency
  • 1055630 2021-001
    Significant Deficiency
  • 1055631 2021-002
    Significant Deficiency
  • 1055633 2021-002
    Significant Deficiency
  • 1055634 2021-002
    Significant Deficiency
  • 1055635 2021-003
    Significant Deficiency
  • 1055636 2021-003
    Significant Deficiency
  • 1055637 2021-003
    Significant Deficiency
  • 1055638 2021-003
    Significant Deficiency
  • 1055639 2021-004
    Significant Deficiency
  • 1055640 2021-004
    Significant Deficiency
  • 1055641 2021-004
    Significant Deficiency
  • 1055642 2021-004
    Significant Deficiency
  • 1055643 2021-005
    Significant Deficiency
  • 1055644 2021-005
    Significant Deficiency
  • 1055645 2021-005
    Significant Deficiency
  • 1055646 2021-005
    Significant Deficiency
  • 1055647 2021-005
    Significant Deficiency
  • 1055648 2021-005
    Significant Deficiency
  • 1055649 2021-005
    Significant Deficiency

Programs in Audit

ALN Program Name Expenditures
16.576 Crime Victim Compensation $301,041
14.267 Continuum of Care Program $57,267
16.575 Crime Victim Assistance $33,903
94.006 Americorps $31,745
16.588 Violence Against Women Formula Grants $26,813
93.788 Opioid Str $16,911
93.994 Maternal and Child Health Services Block Grant to the States $15,472
10.558 Child and Adult Care Food Program $14,904
93.558 Temporary Assistance for Needy Families $6,167